Results 61 to 70 of about 58,194 (262)

Effectiveness and safety of dual influenza and pneumococcal vaccination versus separate administration or no vaccination in older adults: a meta-analysis

open access: yesExpert Review of Vaccines, 2018
Background: The advantages of dual pneumococcal and influenza vaccination in older adults have not been clarified and controversy remains regarding their optimal use. Methods: This meta-analysis was conducted on 25 January 2018 using PubMed, the Cochrane
Mingjuan Yin   +6 more
doaj   +1 more source

Shingles & Pneumococcal Vaccines: Recommendations for Older Adults [PDF]

open access: yes, 2018
As the immune system tends to weaken over time, patients aged 50+ begin having increased risk for certain potentially preventable diseases, especially shingles and pneumonia.
Flinn, Benjamin
core   +1 more source

Burden of Influenza in Patients Visiting Emergency Department for Treatment of Influenza Like Illness at THQ Hospital Shujabad, Pakistan [PDF]

open access: yes, 2020
Background: Viral infection of the respiratory tract is a common illness syndrome in humans. Human respiratory tract is infected by large number of viruses. Self-constraining infections are caused by most of them e.g.
Chaudhry, M. (Mamoona)   +4 more
core  

Green Stool Predominance in Babies and Subsequent Bowel Function at 1–2 Years of Age

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim To study the relationship between bowel function after birth and at 1–2 years of age in the prospective HELMi cohort of term infants. Methods We focused on infants with predominantly green stools (n = 152) for three consecutive weeks in early life and their sex, age, and delivery mode‐matched controls (n = 300), and evaluated bowel ...
L. Typpö   +5 more
wiley   +1 more source

Coverage and influencing factors of influenza and pneumococcal vaccination among urban and rural residents 50 years old and over in Zhejiang province, 2022 – a cross-sectional survey

open access: yesZhongguo gonggong weisheng
ObjectiveTo examine the coverage and influencing factors of influenza and pneumococcal vaccines among urban and rural residents aged ≥ 50 years in Zhejiang province for promoting the vaccination of the two vaccines in the population.
Zixin LIU   +6 more
doaj   +1 more source

Impact of Pneumococcal Conjugate Vaccines on Pneumonia Hospitalizations in High- and Low-Income Subpopulations in Brazil. [PDF]

open access: yes, 2017
BackgroundPneumococcal conjugate vaccines (PCVs) are being used worldwide. A key question is whether the impact of PCVs on pneumonia is similar in low- and high-income populations.
Kürüm, Esra   +7 more
core   +2 more sources

Trends in Hospitalisations Due to Respiratory Syncytial Virus in Swedish Children: A Nationwide Study 2010–2022

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim Respiratory syncytial virus (RSV) infection is a leading cause of paediatric hospitalisations. This study describes annual RSV‐hospitalisation burden of disease, by gestational week of delivery, age and sex among children aged 0–17 years of age in Sweden, for the period 2010/11–2021/22.
Kristian Bolin   +4 more
wiley   +1 more source

The association between life events, social support, and antibody status following thymus-dependent and thymus-independent vaccinations in healthy young adults [PDF]

open access: yes, 2005
This study determined whether stressful life events and social support were related to antibody status following both thymus-dependent and thymus-independent vaccinations. Life events in the previous year and customary social support were measured in 57
Burns, Victoria E.   +4 more
core   +1 more source

Determinants of adult vaccination at inner-city health centers: A descriptive study

open access: yesBMC Family Practice, 2006
Background Pneumococcal polysaccharide vaccination rates among adults 65 years and older or less than 65 years with high risk medical conditions are still below Healthy People 2010 recommended levels of 90%.
Raymund Mahlon   +4 more
doaj   +1 more source

Health economic considerations for pharmacogenomic services in the United Kingdom: The Centre for Excellence in Regulatory Science and Innovation in Pharmacogenomics

open access: yes
British Journal of Clinical Pharmacology, EarlyView.
Dyfrig A. Hughes   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy